Indefinite Delivery Contract 36C26026D0003

Award Date 10/1/25
Last Date to Order 9/30/30
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The key products and services being delivered under this federal contract IDV award are specialized pharmacy services and hazardous compounding for chemotherapy and other intravenous medications to support the Department of Veterans Affairs (VA) healthcare system. The prime contractor, Optum Pharmacy 801, Inc. (doing business as Avella Specialty Pharmacy), a subsidiary of UnitedHealth Group Incorporated, has been awarded a single-award Indefinite Delivery Contract (IDC) worth $6.75 million by...
The Department of Veterans Affairs (VA) has awarded a single-award Indefinite Delivery Contract (IDC) to Optum Pharmacy 801, Inc., a subsidiary of UnitedHealth Group Incorporated, for pharmacy compounding services. The $800,000 IDC has a performance period through November 2029 and allows the VA to issue task orders for specialized pharmaceutical products and services as needed. Under this IDC, Optum Pharmacy 801, Inc. provides customized chemotherapy agents, hazardous sterile preparations,...
The federal contract IDV awarded by the Department of Veterans Affairs (VA) to Optum Pharmacy 601, LLC, a subsidiary of UnitedHealth Group Incorporated, is for the provision of specialized pharmacy compounding services to support the Veterans Integrated Service Network 16 (VISN 16) in the Gulf Coast region. Under this single-award $4.5M Indefinite Delivery Contract, which has a period of performance through September 2024, Optum Pharmacy 601 will deliver a range of customized pharmaceutical...
This federal contract IDV award is a Blanket Purchase Agreement (BPA) between the Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 2 and Optum Pharmacy 801, Inc., a subsidiary of UnitedHealth Group Incorporated. The single-award BPA, valued at up to $1,415,000, provides chemo compounding services to support the VA's oncology and infusion treatment programs when the agency's on-site compounding capabilities are temporarily unavailable. The contract tasks Optum...
The Department of Veterans Affairs Veterans Health Administration (VA-VHA) has awarded an Indefinite Delivery Contract (IDC) to Optum Pharmacy 801, Inc., a subsidiary of UnitedHealth Group Incorporated, for the provision of hazardous sterile compounding services. The contract, valued at $2,433,675.00, has a period of performance through October 1, 2024 and was awarded without any set-aside designation, indicating it was a full and open commercial competition. Under this IDC, the VA-VHA has...
This indefinite delivery contract (IDC) was awarded by the U.S. Department of Veterans Affairs (VA) to Optum Pharmacy 801, Inc., a subsidiary of UnitedHealth Group Incorporated, to provide hazardous chemotherapy compounding services for the VA's Veterans Integrated Service Network (VISN) 10, which covers Ohio, Michigan, and Indiana. The $4,135,790.32 IDC has a period of performance from May 1, 2024 to April 30, 2026. It was a full and open competition without any set-asides. The contract aims to...
This single-award Indefinite Delivery Contract (IDC) was issued by the Department of Veterans Affairs (VA) Veterans Health Administration Veterans Integrated Service Network 20 (VISN 20) to Optum Pharmacy 801, Inc., a subsidiary of UnitedHealth Group Incorporated. The $2,500,000 contract provides pharmacy compounding services, with a focus on chemotherapy, hazardous sterile preparations, and specialized pharmaceutical solutions, primarily to support the VA healthcare system. The contract...
The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded an Indefinite Delivery Contract (IDC) to Optum Pharmacy 801, Inc., a subsidiary of UnitedHealth Group Incorporated, to provide nationwide pharmacy compounding services. The contract has a ceiling value of $10,000,000 and a period of performance through October 31, 2025. Under this IDC, Optum Pharmacy 801, Inc. (doing business as Avella Specialty Pharmacy) will provide highly specialized pharmaceutical...
The federal contract IDV award is a multiple-award Federal Supply Schedule (FSS) contract under Schedule 65 IB for drugs, pharmaceuticals, and hematology-related products, awarded by the Department of Veterans Affairs to Vantive US Healthcare LLC. The contract has a ceiling value of $25,000 and a period of performance through February 1, 2025. The purpose of this IDV is to establish pre-competed procurement mechanisms that allow rapid acquisition of medical supplies and pharmaceuticals for the...
The federal contract IDV award is for Chemo Compounding Services provided by Optum Pharmacy 801, Inc. (dba Avella Specialty Pharmacy), a subsidiary of UnitedHealth Group Incorporated. As the prime contractor, Avella will be responsible for compounding customized chemotherapy agents, hazardous sterile preparations, intravenous solutions, and other medications based on patient-specific orders to support the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) healthcare...
  • 36C26026D0003
    Indefinite Delivery Contract
  • 1
    Federal Contract Awards

The federal contract IDV is an Indefinite Delivery Contract awarded by the U.S. Department of Veterans Affairs (VA), Veterans Integrated Service Network (VISN) 20, to Optum Pharmacy 801, Inc., a subsidiary of UnitedHealth Group Incorporated. The contract, valued at up to $20,000,000, is for specialized pharmaceutical compounding services, particularly in the areas of chemotherapy, hazardous drug preparation, and intravenous solutions, to support the VA's Veterans Health Administration.

The contract does not have a set-aside designation, indicating it was a full and open competition. Optum Pharmacy 801, Inc. has established itself as a critical supplier of these services to the VA, securing multiple Indefinite Delivery Contracts (IDCs) and Blanket Purchase Agreements (BPAs) with the agency across various VISNs. The original solicitation was for a five-year IDIQ contract to provide contingency pharmacy compounding services, including sterile IV admixtures, to the Spokane VA Medical Center. The place of performance is the contractor's facility in Phoenix, Arizona, with delivery to the Spokane facility. The comprehensive pharmaceutical inventory spans a wide range of medical needs, covering emergency, routine, and specialized treatment requirements.

Generated 10/2/25, 11:07 AM